Significant Ownership of Paradigm Biocapital Advisors LP

Signature - Title
/s/ David K. Kim - David K. Kim / Authorized Signatory
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Paradigm Biocapital Advisors LP.

Notify me when Paradigm Biocapital Advisors LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Paradigm Biocapital Advisors LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
OLMA Olema Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 9.99% $37.4M 7.43M Paradigm BioCapital Advisors LP Dec 31, 2024
URGN UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share 9% $84.1M $37.6M 4.22M +80.8% Paradigm BioCapital Advisors LP Sep 30, 2025
VOR VOR Biopharma Inc. Common Stock, 0.0001 par value per share 8.6% $43.8M 1.75M Paradigm BioCapital Advisors LP Nov 11, 2025
MRUS Merus N.V. Common Shares, (euro)0.09 nominal value per share 6.2% $440M $105M 4.67M +31.5% Paradigm BioCapital Advisors LP Sep 30, 2025
EWTX Edgewise Therapeutics, Inc. Common Stock, $0.0001 par value per share 5% $73M 4.74M Paradigm BioCapital Advisors LP Jan 27, 2025
LXEO Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share 5% $33M 3.67M Paradigm BioCapital Advisors LP Nov 13, 2025
AGIO Agios Pharmaceuticals, Inc. Common Stock, $0.001 par value per share 4.9% $115M -$6.2M 2.87M -5.1% Paradigm BioCapital Advisors LP Sep 30, 2025
JANX Janux Therapeutics, Inc. Common Stock, $0.001 par value per share 4.9% $73.4M -$15M 2.92M -16.9% Paradigm BioCapital Advisors LP Jun 30, 2025
LENZ LENZ Therapeutics, Inc. Common Stock, $0.00001 par value per share 3.8% $50M -$16.1M 1.07M -24.4% Paradigm BioCapital Advisors LP Sep 30, 2025
IRON Disc Medicine, Inc. Common Stock, $0.0001 par value per share 3.5% $57.1M 1.21M Paradigm BioCapital Advisors LP Mar 31, 2025
CDTX Cidara Therapeutics, Inc. Common Stock, $0.0001 par value per share 3.3% $92M -$16M 961K -14.8% Paradigm BioCapital Advisors LP Sep 30, 2025
COGT Cogent Biosciences, Inc. Common Stock, $0.001 par value per share 2.3% $45.3M -$103M 3.16M -69.5% Paradigm BioCapital Advisors LP Sep 30, 2025
YMAB Y-mAbs Therapeutics, Inc. Common Stock, $0.0001 par value per share 0% $0 0 Paradigm BioCapital Advisors LP Sep 30, 2025
KURA Kura Oncology, Inc. Common Stock, $0.0001 par value per share 0% $0 0 Paradigm BioCapital Advisors LP Dec 31, 2024
PLRX Pliant Therapeutics, Inc. Common Stock, $0.0001 par value per share 0% $0 0 Paradigm BioCapital Advisors LP Mar 31, 2025

Schedules 13D/G Reported by Paradigm Biocapital Advisors LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.